The Filings Report

Insulet Corporation

PODDNasdaqCIK 1145197Healthcare / Medical Devicesfiscal year ends December67 quarters since 2010

Revenue, Q3 FY2026
$842M
+19.2% on Q3 FY2025
Net income
$141M
+61.1% on Q3 FY2025
Free cash flow
$66M
−33.7% on Q3 FY2025
Diluted EPS
$2.03
+63.7% on Q3 FY2025
Revenue, TTM
$3.2B
trailing four quarters
Net margin, TTM
13.4%
net income $429M
Free cash flow, TTM
$260M
$509M less $249M capex
Cash and equivalents
—
long-term debt —, Sep 30, 2026
Shares, 12-month change
−1.4%
69M shares, Sep 30, 2026
Buybacks, TTM
$300M
3.0% of market value
Dividends, TTM
—
no yield
Market value
$10.2B
at the close, buybacks

Latest quarter Q3 FY2026, filed November 4, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Insulet Corporation reported revenue of $842M, +19.2% on Q3 FY2025, and net income of $141M (+61.1%). Operating margin was 22.5%. Free cash flow, operating cash flow less capital expenditures, was $66M ($124M less $57M). Diluted earnings per share were $2.03.

Share price

Daily candlesticks from November 11, 2024 to November 6, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.

PODD daily priceSplit-adjusted, US dollars; an earnings release
Nov 6, 2026O $155.60 · H $155.60 · L $143.28 · C $146.51 · −6.16% on the dayOver the range: −54.70%, Nov 7, 2025 to Nov 6, 2026
$113$177$241$305$369Nov 25Jan 26Apr 26Jun 26Aug 26Nov 26

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of November 4, 2026.

Revenue and net incomeRevenueNet income
$0$250M$500M$750M$1.0BQ4'22, Net income: $17MQ4'22Q1'23, Revenue: $358MQ1'23, Net income: $24MQ1'23Q2'23, Revenue: $397MQ2'23, Net income: $27MQ2'23Q3'23, Revenue: $433MQ3'23, Net income: $52MQ3'23Q4'23, Revenue: $510MQ4'23, Net income: $103MQ4'23Q1'24, Revenue: $442MQ1'24, Net income: $52MQ1'24Q2'24, Revenue: $489MQ2'24, Net income: $189MQ2'24Q3'24, Revenue: $544MQ3'24, Net income: $78MQ3'24Q4'24, Revenue: $598MQ4'24, Net income: $101MQ4'24Q1'25, Revenue: $569MQ1'25, Net income: $35MQ1'25Q2'25, Revenue: $649MQ2'25, Net income: $23MQ2'25Q3'25, Revenue: $706MQ3'25, Net income: $88MQ3'25Q4'25, Revenue: $784MQ4'25, Net income: $102MQ4'25Q1'26, Revenue: $762MQ1'26, Net income: $91MQ1'26Q2'26, Revenue: $802MQ2'26, Net income: $95MQ2'26Q3'26, Revenue: $842MQ3'26, Net income: $141MQ3'26$0$250M$500M$750M$1.0BQ4'22, Net income: $17MQ4'22Q1'23, Revenue: $358MQ1'23, Net income: $24MQ1'23Q2'23, Revenue: $397MQ2'23, Net income: $27MQ2'23Q3'23, Revenue: $433MQ3'23, Net income: $52MQ3'23Q4'23, Revenue: $510MQ4'23, Net income: $103MQ4'23Q1'24, Revenue: $442MQ1'24, Net income: $52MQ1'24Q2'24, Revenue: $489MQ2'24, Net income: $189MQ2'24Q3'24, Revenue: $544MQ3'24, Net income: $78MQ3'24Q4'24, Revenue: $598MQ4'24, Net income: $101MQ4'24Q1'25, Revenue: $569MQ1'25, Net income: $35MQ1'25Q2'25, Revenue: $649MQ2'25, Net income: $23MQ2'25Q3'25, Revenue: $706MQ3'25, Net income: $88MQ3'25Q4'25, Revenue: $784MQ4'25, Net income: $102MQ4'25Q1'26, Revenue: $762MQ1'26, Net income: $91MQ1'26Q2'26, Revenue: $802MQ2'26, Net income: $95MQ2'26Q3'26, Revenue: $842MQ3'26, Net income: $141MQ3'26$0$250M$500M$750M$1.0BQ4'22, Net income: $17MQ1'23, Revenue: $358MQ1'23, Net income: $24MQ1'23Q2'23, Revenue: $397MQ2'23, Net income: $27MQ3'23, Revenue: $433MQ3'23, Net income: $52MQ3'23Q4'23, Revenue: $510MQ4'23, Net income: $103MQ1'24, Revenue: $442MQ1'24, Net income: $52MQ1'24Q2'24, Revenue: $489MQ2'24, Net income: $189MQ3'24, Revenue: $544MQ3'24, Net income: $78MQ3'24Q4'24, Revenue: $598MQ4'24, Net income: $101MQ1'25, Revenue: $569MQ1'25, Net income: $35MQ1'25Q2'25, Revenue: $649MQ2'25, Net income: $23MQ3'25, Revenue: $706MQ3'25, Net income: $88MQ3'25Q4'25, Revenue: $784MQ4'25, Net income: $102MQ1'26, Revenue: $762MQ1'26, Net income: $91MQ1'26Q2'26, Revenue: $802MQ2'26, Net income: $95MQ3'26, Revenue: $842MQ3'26, Net income: $141MQ3'26

Net income losses drawn in red.

Free cash flow
−$50M$0$50M$100M$150M$200MQ4'22, Free cash flow: −$14MQ4'22Q1'23, Free cash flow: −$10MQ1'23Q2'23, Free cash flow: $28MQ2'23Q3'23, Free cash flow: $36MQ3'23Q4'23, Free cash flow: $16MQ4'23Q1'24, Free cash flow: $66MQ1'24Q2'24, Free cash flow: $64MQ2'24Q3'24, Free cash flow: $82MQ3'24Q4'24, Free cash flow: $94MQ4'24Q1'25, Free cash flow: $52MQ1'25Q2'25, Free cash flow: $178MQ2'25Q3'25, Free cash flow: $100MQ3'25Q4'25, Free cash flow: $48MQ4'25Q1'26, Free cash flow: $90MQ1'26Q2'26, Free cash flow: $56MQ2'26Q3'26, Free cash flow: $66MQ3'26−$50M$0$50M$100M$150M$200MQ4'22, Free cash flow: −$14MQ4'22Q1'23, Free cash flow: −$10MQ1'23Q2'23, Free cash flow: $28MQ2'23Q3'23, Free cash flow: $36MQ3'23Q4'23, Free cash flow: $16MQ4'23Q1'24, Free cash flow: $66MQ1'24Q2'24, Free cash flow: $64MQ2'24Q3'24, Free cash flow: $82MQ3'24Q4'24, Free cash flow: $94MQ4'24Q1'25, Free cash flow: $52MQ1'25Q2'25, Free cash flow: $178MQ2'25Q3'25, Free cash flow: $100MQ3'25Q4'25, Free cash flow: $48MQ4'25Q1'26, Free cash flow: $90MQ1'26Q2'26, Free cash flow: $56MQ2'26Q3'26, Free cash flow: $66MQ3'26−$50M$0$50M$100M$150M$200MQ4'22, Free cash flow: −$14MQ1'23, Free cash flow: −$10MQ1'23Q2'23, Free cash flow: $28MQ3'23, Free cash flow: $36MQ3'23Q4'23, Free cash flow: $16MQ1'24, Free cash flow: $66MQ1'24Q2'24, Free cash flow: $64MQ3'24, Free cash flow: $82MQ3'24Q4'24, Free cash flow: $94MQ1'25, Free cash flow: $52MQ1'25Q2'25, Free cash flow: $178MQ3'25, Free cash flow: $100MQ3'25Q4'25, Free cash flow: $48MQ1'26, Free cash flow: $90MQ1'26Q2'26, Free cash flow: $56MQ3'26, Free cash flow: $66MQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$500M$1.0B$1.5BQ4'22, Long-term debt: $1.4BQ4'22Q1'23, Long-term debt: $1.4BQ1'23Q2'23, Long-term debt: $1.4BQ2'23Q3'23Q4'23Q1'24Q2'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26$0$500M$1.0B$1.5BQ4'22, Long-term debt: $1.4BQ4'22Q1'23, Long-term debt: $1.4BQ1'23Q2'23, Long-term debt: $1.4BQ2'23Q3'23Q4'23Q1'24Q2'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26$0$500M$1.0B$1.5BQ4'22, Long-term debt: $1.4BQ1'23, Long-term debt: $1.4BQ1'23Q2'23, Long-term debt: $1.4BQ3'23Q1'24Q3'24Q1'25Q3'25Q1'26Q3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed November 4, 2026.

Insulet Corporation income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 4, 2026Q2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 18, 2026Q3 FY2025ended Sep 30, 2025filed Nov 6, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 9, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue842802762784706649569598+19.2%
Cost of revenue210239233215196197160167+7.0%
Gross profit632563529569510452409431+23.9%
Research and development9288909177736061+18.7%
Selling, general and administrative351345317331315258261261+11.3%
Operating income19013012214611812189109+61.3%
Other income (expense)0(1)13121(2)0−101.7%
Pretax income1771191131401232848111+44.3%
Income tax362422393561311+2.6%
Net income1419591102882335101+61.1%
Diluted EPS ($)2.031.371.30—1.240.320.50—+63.7%
Diluted shares (millions)696970—717174——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed November 4, 2026.

Insulet Corporation balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 4, 2026Q2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 18, 2026Q3 FY2025ended Sep 30, 2025filed Nov 6, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 9, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents—————————
Short-term investments—————————
Total current assets2,0421,8491,7101,9141,8592,2802,3281,891+9.8%
Total assets3,4153,1652,9873,1903,0293,4693,5173,088+12.7%
Total current liabilities8147446886806481,010520528+25.7%
Long-term debt—————————
Total liabilities1,8361,7431,6851,6751,6452,0062,1871,876+11.6%
Stockholders’ equity1,5791,4221,3031,5151,3841,4631,3311,212+14.1%
Shares outstanding (millions)6969697070707070—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed November 4, 2026.

Insulet Corporation cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 4, 2026Q2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 18, 2026Q3 FY2025ended Sep 30, 2025filed Nov 6, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 9, 2025Q4 FY2024ended Dec 31, 2024filed Feb 21, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow1248811418312619764148−1.8%
Capital expenditures57332413526191254+123.0%
Free cash flow (CFO − capex)665690481001785294−33.7%
Depreciation and amortization2827262422222222+28.2%
Share repurchases003000303000−100.0%
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 18, 2026.

Income statement

Insulet Corporation income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 18, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 23, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 24, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 22, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Feb 29, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 28, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Aug 9, 2011FY2009ended Dec 31, 2009filed Aug 9, 2011
Revenue2,7082,0721,6971,3051,0999047385644643672642312472111529766
Cost of revenue768626537500347322258194187156131104135119865348
Gross profit1,9401,4461,16080675258248037027721113312711292674418
Research and development30122020518016014713295765643282224221713
Selling, general and administrative1,165917735588466384298248857260586451442727
Operating income47430922038126525027(7)(11)(49)(9)(29)(36)(42)(39)(59)
Other income (expense)14(5)2(1)(2)31(1)3(16)(13)(39)(16)(16)(15)(23)(13)
Pretax income340300215102110155(27)(27)(61)(48)(45)(52)(57)(61)(72)
Income tax92(118)854332000000(11)——
Net income2474182065177123(27)(29)(74)(51)(45)(52)(46)(61)(72)
Diluted EPS ($)3.485.782.940.070.240.100.190.05(0.46)(0.48)———————
Diluted shares (millions)72747470696662615857———————

Balance sheet

Insulet Corporation balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 18, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 23, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 24, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 22, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Feb 29, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 28, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Aug 9, 2011FY2009ended Dec 31, 2009filed Aug 9, 2011
Cash and equivalents—————9072141142731371231511505794113128
Short-term investments————040162175—————————
Total current assets1,9141,8911,5831,3141,3301,249591461547370191208198110133142—
Total assets3,1903,0882,5882,2512,0491,8731,143929840457275297288198221156—
Total current liabilities6805284513652292081581168956654442482819—
Long-term debt———1,3741,2491,04488859256633317216411410410969—
Total liabilities1,6751,8761,8561,7751,4931,2691,06771766139324121316315413990—
Stockholders’ equity1,5151,2127334765566047621217963348412544836662
Shares outstanding (millions)707070706966635958585756555348——

Cash flow statement

Insulet Corporation cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 18, 2026FY2024ended Dec 31, 2024filed Feb 21, 2025FY2023ended Dec 31, 2023filed Feb 23, 2024FY2022ended Dec 31, 2022filed Feb 24, 2023FY2021ended Dec 31, 2021filed Feb 24, 2022FY2020ended Dec 31, 2020filed Feb 24, 2021FY2019ended Dec 31, 2019filed Feb 26, 2020FY2018ended Dec 31, 2018filed Feb 26, 2019FY2017ended Dec 31, 2017filed Feb 22, 2018FY2016ended Dec 31, 2016filed Feb 28, 2017FY2015ended Dec 31, 2015filed Feb 29, 2016FY2014ended Dec 31, 2014filed Feb 26, 2015FY2013ended Dec 31, 2013filed Feb 28, 2014FY2012ended Dec 31, 2012filed Feb 28, 2013FY2011ended Dec 31, 2011filed Feb 28, 2012FY2010ended Dec 31, 2010filed Aug 9, 2011FY2009ended Dec 31, 2009filed Aug 9, 2011
Operating cash flow569430146119(68)8498364116(13)93(29)(25)(36)(49)
Capital expenditures19212576123112129164157742211117111173
Free cash flow (CFO − capex)37830570(4)(180)(45)(65)(121)(32)(6)(23)(3)(4)(40)(37)(42)(52)
Depreciation and amortization9081736357552816141416121211955
Share repurchases6000——————————————
Dividends paid—————————————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 9, 2024 to November 9, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$162K
1 purchases by 1 insider; officers and directors $162K
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$3M
6 purchases by 4 insiders; officers and directors $3M
Sold, twelve months
$602K
2 sales by 2 insiders; officers and directors $602K

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 1, 2026Pease FlaviaEVP & CFOtax withholding1,882$130.79$246K17,357Oct 5, 2026
Sep 30, 2026Mazelsky Jonathan JayDirectoraward141$130.47$18K1,496Oct 2, 2026
Sep 30, 2026Huffines Robert LutherDirectoraward178$130.47$23K2,627Oct 2, 2026
Aug 21, 2026McEvoy AshleyPresident and CEO, Directoropen-market buy1,100$147.47$162K23,731Aug 24, 2026
Aug 1, 2026Davis Lisa BlairSVP, Chief HR Officertax withholding244$165.35$40K4,453Aug 4, 2026
Jul 1, 2026Mazelsky Jonathan JayDirectoraward1,355$0.00—1,355Jul 2, 2026
Jun 30, 2026Huffines Robert LutherDirectoraward151$152.25$23K2,449Jul 7, 2026
Jun 30, 2026Huffines Robert LutherDirectoraward144$159.79$23K2,442Jul 2, 2026
Jun 3, 2026Stonesifer Timothy C.Directoropen-market buy2,790$143.51$400K9,041Jun 4, 2026
Jun 3, 2026Borio LucianaDirectoropen-market sale418$143.27$60K4,329Jun 4, 2026
Jun 3, 2026Weatherman Elizabeth HDirectoropen-market buy3,450$144.20$497K10,352Jun 3, 2026
May 20, 2026Weatherman Elizabeth HDirectoraward1,660$0.00—6,902May 21, 2026
May 20, 2026Stonesifer Timothy C.Directoraward1,660$0.00—6,251May 21, 2026
May 20, 2026Scannell Timothy JDirectoraward1,660$0.00—33,024May 21, 2026
May 20, 2026Minogue Michael RDirectoraward1,660$0.00—2,438May 21, 2026
May 20, 2026Huffines Robert LutherDirectoraward1,660$0.00—2,298May 21, 2026
May 20, 2026Hopfield JessicaDirectoraward1,660$0.00—29,355May 21, 2026
May 20, 2026Frederick Wayne A.I.Directoraward1,660$0.00—3,818May 21, 2026
May 20, 2026Borio LucianaDirectoraward1,660$0.00—4,747May 21, 2026
May 13, 2026McEvoy AshleyPresident and CEO, Directortax withholding1,411$148.84$210K22,551May 15, 2026
Apr 1, 2026Panos MichaelEVP and CCOaward2,777$0.00—2,782Apr 2, 2026
Mar 31, 2026Huffines Robert LutherDirectoraward111$209.84$23K638Apr 2, 2026
Feb 27, 2026Singh PremSVP, Global Operationstax withholding62$246.61$15K6,891Mar 3, 2026
Feb 27, 2026Singh PremSVP, Global Operationstax withholding207$246.61$51K6,953Mar 3, 2026
Feb 27, 2026Cousin LaetitiaSVP, Reg, Quality & Compliancetax withholding200$246.61$49K5,727Mar 3, 2026

Full insider history for Insulet Corporation, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
INSULET CORPORATION, CIK 1145197 on EDGAR
Extract generated
November 8, 2026
Withheld
4 line-years whose four quarters do not sum to the filed year: gross profit FY2014, revenue FY2014, other income FY2018, revenue FY2022
Repaired
2 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: income tax FY2013, income tax FY2014
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: GeneralAndAdministrativeExpense, SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: AvailableForSaleSecuritiesDebtSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: not filed

The data

The statements on this page as files, generated November 8, 2026.

JSON file
/data/financials/PODD.json